BBOX1 promotes triple-negative breast cancer progression by controlling IP3R3 stability

被引：7
|
作者：
Liao, Chengheng [1 ]
Zhang, Qing [1 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA
来源：
MOLECULAR & CELLULAR ONCOLOGY | 2020年 / 7卷 / 06期
关键词：
TNBC; 2-OG dependent enzyme; therapeutic target;
D O I：
10.1080/23723556.2020.1813526
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Limited therapeutic options impede the clinical outcome of triple-negative breast cancer (TNBC). Our recent study uncovered a novel signaling pathway implicating gamma-butyrobetaine hydroxylase 1 (BBOX1) in the control of cell growth in TNBC, via inositol 1, 4, 5-trisphosphate receptor type 3 (IP3R3) mediated calcium signaling which is essential for cellular energy metabolism.
引用
收藏
页数：3
相关论文
共 50 条
  • [21] The deubiquitinase BRCC3 increases the stability of ZEB1 and promotes the proliferation and metastasis of triple-negative breast cancer cells
    Huang, Qidi
    Zheng, Shurong
    Gu, Huayan
    Yang, Zhi
    Lu, Yiqiao
    Yu, Xia
    Guo, Guilong
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2024, 56 (04): : 564 - 575
  • [22] An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
    Lu, Xun-Xi
    Yang, Wen-Xiao
    Pei, Yu -Chen
    Luo, Hong
    Li, Xiao-Guang
    Wang, Yun-Jin
    Zhang, Guo-Liang
    Ling, Hong
    Shao, Zhi-Ming
    Hu, Xin
    CANCER RESEARCH, 2023, 83 (12) : 2000 - 2015
  • [23] MicroRNAs in regulation of triple-negative breast cancer progression
    Dominika Piasecka
    Marcin Braun
    Radzislaw Kordek
    Rafal Sadej
    Hanna Romanska
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 1401 - 1411
  • [24] MicroRNAs in regulation of triple-negative breast cancer progression
    Piasecka, Dominika
    Braun, Marcin
    Kordek, Radzislaw
    Sadej, Rafal
    Romanska, Hanna
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (08) : 1401 - 1411
  • [25] SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1
    Deng, Ling
    Liao, Li
    Zhang, Yin-Ling
    Yang, Shao-Ying
    Hu, Shu-Yuan
    Andriani, Lisa
    Ling, Yun-Xiao
    Ma, Xiao-Yan
    Zhang, Fang-Lin
    Shao, Zhi-Ming
    Li, Da-Qiang
    SCIENCE ADVANCES, 2024, 10 (14)
  • [26] MicroRNA-301a-3p promotes triple-negative breast cancer progression through downregulating MEOX2
    Liu, Heng
    Wang, Gangyue
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (03)
  • [27] Claudin 1, 3, 4, and 7 expression in triple-negative breast cancer
    Ko, Beom Seok
    Kim, Hee Jeong
    Yu, Jong Han
    Lee, Jong Won
    Sohn, Byung Ho
    Kim, Sung-Bae
    Gong, Gyungyub
    Ahn, Sei-Hyun
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [28] USP10 promotes the progression of triple-negative breast cancer by enhancing the stability of TCF4 protein
    Yang, Jing-ru
    Lu, Yong-bin
    Su, Hong-xin
    Xiao, Yi
    Pan, Qing
    Su, Fei
    Zhang, Xiao-bin
    Zhu, Kai-li
    Guan, Quan-lin
    Ling, Xiao-ling
    BIOCHEMICAL PHARMACOLOGY, 2023, 218
  • [29] Serglycin proteoglycan promotes progression and metastasis of triple-negative breast cancers
    Johnstone, Cameron N.
    Harris, Nathaniel
    Ranson, Marie
    Rustgi, Anil K.
    Anderson, Robin L.
    CANCER RESEARCH, 2015, 75
  • [30] The oncogenic miR-429 promotes triple-negative breast cancer progression by degrading DLC1
    Li, Yao
    Meng, Xue
    Luo, Yuqing
    Luo, Shuai
    Li, Jin
    Zeng, Jiafei
    Huang, Xiang
    Wang, Jinjing
    AGING-US, 2023, 15 (18): : 9809 - 9821
12345